FDA issues a press release to request information (RFI) on sesame as an allergen for USA consumers. The Agency seeks data and incidences of sesame allergens as the USA does not currently require disclosure of sesame as one of the 8 major USA allergens. (In other countries, sesame is a required allergen declaration.)
Manufacturers should not change their allergen declarations (i.e., “Contains:” statement) until FDA formally makes a new rule.
The comment period opens October 30, 2018 and will remain open for 60 days.
All submissions received must include the Docket No. FDA-2018-N-3809.
Comments and information can be submitted to
To submit electronic comments, go to https://www.regulations.gov and search for Docket No. FDA-2018-N-3809.
Written comments must be sent to:
Docket Management Staff (HFA-305)
Food and Drug Administration
5630 Fishers Lane, Room 1061
Rockville, MD 20852